Therapeutic effects of Erbin inhibitor on spinal cord contusion in mice.

Erbin has been shown to maintain the integrity of cell structure, regulate the proliferation and differentiation of cell and transconduct signals in the pathways. This study was conducted to assess the therapeutic effects of an Erbin inhibitor on spinal cord contusion in mice. Spinal contusion models of mouse were constructed and treated with an Erbin inhibitor. The experimental animals were divided into control (normal animal without any treatment), models with spinal cord injury (SIM), and models receiving Erbin inhibitor (Inhibitor). The contents of 5-hydroxytryptamine (5-HT) and reactive oxygen species (ROS) in the brain and spinal cord tissues were measured using ELISA. The expression of ERK1/2, MAPK, NF-kB and NRG1 was quantified using qRT-PCR, Western blot analysis and immunohistochemistry. Flow cytometry was used to determine the formation of macrophages. Erbin interference vector was constructed and its interference effect on the expression of these genes was characterized in cultured bone marrow cells. Spinal contusion models were successfully constructed. Administering Erbin inhibitor inhibited the expression of ERK1/2, MAPK and NF-kB and up-regulated the expression of NRG1. Flow cytometry showed that Erbin inhibitor induced the formation of a large number of macrophages, which are beneficial to the recovery of spinal cord injury. Experiments with Erbin interference vector showed similar impacts on the expression of genes at cellular level as the inhibitor did. Our work has demonstrated that the Erbin inhibitor is very effective to treat spinal cord contusion in mice. The possible mechanism of therapeutic effect is that the inhibitor suppresses the ERK1/2/MAPK and/or NF-kB/MAPK signal pathways and enhances the NRG1-ErbB signaling pathway by reducing the expression of Erbin, leading to the inhibition of apoptosis, promotion of proliferation and differentiation, and subsequent repair of the damaged spinal cord.